Close menu
May 31, 2024 Global Threats Toxic Exposures

Global Threats

Bill Gates Invests Millions in ‘Climate Vaccines’ to Reduce Methane Emissions From Cows

A Boston-based ag-biotech startup recently raised $26.5 million to “reduce greenhouse gas emissions” via the development of a “methane vaccine.” Breakthrough Energy Ventures, founded by Gates, led the financing round.

bill gates, a cow, hand holding vaccine with globe

Bill Gates has long been a proponent of vaccines in general and more recently,  mRNA vaccine technology.

Now, he may have his sights set on developing a vaccine to combat climate change by targeting the methane emissions of livestock.

ArkeaBio, a Boston-based ag-biotech startup, recently raised $26.5 million in a Series A financing round to “reduce greenhouse gas emissions” via the development of a “methane vaccine,” the company announced in a May 8 press release.

Breakthrough Energy Ventures, founded by Gates and which first invested in ArkeaBio in 2022, led the financing round.

The company said:

“ArkeaBio’s vaccine will provide an innovative, cost-effective, and scalable solution to reduce the world’s livestock methane emissions, which currently generate the equivalent of 3 Billion Tonnes of CO2 annually and represent 6% of annual Greenhouse gas emissions.”

ArkeaBio claims its “vaccination-based approach allows for much-needed decarbonization of global meat and dairy products across multiple geographies, supporting greater sustainability in agriculture.”

Other investors in the recently completed financing round include The Grantham Foundation for the Protection of the Environment, AgriZeroNZ — a “partnership between the New Zealand government and major agribusinesses” — Rabo Ventures, Overview Capital and The51 Food & AgTech Fund.

“The funds raised in this Series A financing will play a pivotal role in expanding the research, development and deployment of the vaccine, including large-scale field trials and engagement along the supply chain,” ArkeaBio said in its press release.

“Climate change is the greatest challenge humanity has ever faced,” said ArkeaBio CEO Colin South. “It is the race of our lives. This capital raise allows us to continue to create the tools necessary for farmers to achieve globally relevant reductions in livestock methane emissions.”

Critics of the project who spoke with The Defender disagreed, suggesting “climate change vaccines” are not feasible but will instead help international organizations such as the World Economic Forum, nonprofits like the Bill & Melinda Gates Foundation and Big Pharma attain more control over society.

Immunologist and biochemist Jessica Rose, Ph.D. told The Defender:

“The ‘climate’ is something that can be used against all people, no matter what, because we all breathe air and drink water. This is why it is a perfect ‘item of control’ being used to engineer panic. A new ‘deadly virus/vaccine’ campaign would be less effective in this way, following the colossal failure of the ‘COVID-19 measures.’

“To me, ‘climate change’ is a catchphrase to mask the damage being done to our environment by mass polluters.”

Michael Rectenwald, Ph.D., author of “The Great Reset and the Struggle for Liberty: Unraveling the Global Agenda,” said that “climate change vaccines” are part of a broader “false narrative.”

Rectenwald said:

“It’s not surprising that these Neo-Malthusian control freaks, psychopaths and government-backed monopolistic profiteers are teaming up to usher in this false narrative. ‘Climate change’ is being used by Big Pharma, the WEF [World Economic Forum], Bill Gates, the Rockefeller Foundation, and their regime puppets as a pretense to promote vaccines and control society.”

Scott C. Tips, president of the National Health Federation, said “climate change vaccines” would also give Big Pharma another avenue to promote mRNA technology.

“Such vaccines would certainly incorporate dangerous mRNA technology, just as tetanus shots now do,” he said.

ArkeaBio is not Gates’ only foray into the development of “solutions” related to methane emissions from livestock.

In November 2023, the Bill & Melinda Gates Foundation granted $4.5 million to Indiana-based animal health biotech company BiomEdit to “deliver a safe and affordable solution that consistently produces significant livestock-related enteric methane emissions reduction.”

Ginkgo Bioworks, a Gates-backed biotech firm, and Elanco, which previously received Gates Foundation grants, launched BiomEdit in 2022.

The push for ‘centralized, unaccountable and coercive control’

Agricultural experts told The Defender that even if the premise of “climate change vaccines” is correct, livestock-generated methane is a minor contributor to overall carbon emissions.

“These vaccines are not needed,” said André Leu, D.Sc., international director of Regeneration International, author and regenerative organic farmer. “They are yet another cost for farmers, further weakening their net income and transferring this to the multinational corporations. They are based on a very poor understanding of greenhouse gas contributions to climate change.

Leu noted that the contribution of methane is at most 1.6% of greenhouse gases. “Most methane emissions come from leaking gas, oil wells and permafrost melting. Ruminants are a very small percentage. The bulk of this comes from Confined Animal Feeding Operations” — also known as factory farms.

Experts also suggested that other means of reducing such methane emissions exist.

Methane from cattle and other livestock belch is produced by microbes in their intestinal tracks through the normal fermentation of feed, noted James Lyons-Weiler, Ph.D., a research scientist and author.

“We don’t need to vaccinate every cow to cause their immune systems to attack these microbes to reduce methane,” he said. “Permacultural practices produce high-quality feed easier to digest that produces less methane than low-quality feeds.”

Lyons-Weiler said that any vaccine attacking animals’ immune systems with the goal of reducing their methane emissions may put the animals’ health at risk and may also endanger the meat industry.

He said:

“An additional concern is that cattle everywhere will develop serious gastrointestinal illnesses as their immune systems attack these naturally occurring methane-producing non-pathogenic organisms.

“Entire ‘vaccinated’ herds will become commercially unviable, and the meat industry will be destroyed. It is entirely reasonable to suspect this is the ultimate goal of this insane endeavor.”

Some experts suggested that another potential impetus behind the push for “climate change vaccines” is the One Health concept, championed by the World Health Organization (WHO), which promotes the idea that public health policies should view human health, and also animal and environmental health, as being interdependent.

Rose suggested that “from the point of view of control,” the “climate change vaccines” may be connected to One Health. Tips agreed, calling One Health “a particularly nefarious scheme” intended to “fool the populace, raise lots of money and enact globalist goals of power over the world’s population.”

The implementation of One Health’s goals would also involve “synthetic means and centralized, unaccountable and coercive control,” Tips said.

Proponents of One Health claim that as a result of climate change, zoonotic diseases — which jump from animals to humans — are likely to increase in number and severity, thereby necessitating the unified approach the concept champions.

But Rectenwald disputed this argument. “The origin of the last pandemic was not zoonotic at all,” he said. “The coronavirus was produced in a lab, just like the vaccines.”

Big Pharma, WEF pushing for ‘vaccines to fight climate-sensitive diseases’

ArkeaBio has not announced plans to develop similar “climate change vaccines” for humans. But some Big Pharma firms are using the threat of climate change to push for increased vaccination, which they claim will help mitigate a climate catastrophe.

An April 2023 article, “Vaccine innovation is a critical response to the climate crisis,” Thomas Triomphe, Sanofi’s executive vice president of vaccines, claimed that “Continued innovation of vaccines to fight climate-sensitive diseases will undoubtedly be a critical tool in the public health response.”

A December 2023 GSK article titled, “In the face of climate change, vaccines play a crucial but underestimated role,” claimed that “As warming temperatures and extreme weather events exacerbate the spread of infectious diseases, maximising the role of vaccines can help mitigate the impact of climate change.”

In a July 2023 interview with The Guardian, Pascal Soriot, CEO of AstraZeneca, said the climate crisis is “affecting us all through respiratory diseases, cancers, health conditions, infectious diseases” and that “This crisis is actually a health crisis.”

And a November 2023 WEF article suggests that “climate change could help spread viruses like malaria, dengue and Zika to higher latitudes and expose more people.”

In response, the WEF suggests that its Climate and Health Initiative “is helping to develop the kind of quantification and analysis that will identify the populations most at risk, so the healthcare community might proactively address the threats.”

“We can act now to bolster the infrastructure and push the vaccines that should be developed or drugs that need more production capacity,” the article states. “Unlike COVID-19, we have a chance to get ahead of the problem. We should take it.”

This article was funded by critical thinkers like you.

The Defender is 100% reader-supported. No corporate sponsors. No paywalls. Our writers and editors rely on you to fund stories like this that mainstream media won’t write.

Please Donate Today

‘Pandemic preparedness’ another name for increased surveillance?

ArkeaBio and Bill Gates aren’t the only ones actively involved in the development of purported health-related solutions to climate change.

In May, the Rockefeller Foundation and the WHO announced an initiative “to cultivate global networks for pathogen detection and strengthen pandemic preparedness capabilities, including broadening surveillance for diseases worsened by rising temperatures and extreme weather.”

The Rockefeller Foundation is investing $5 million in the WHO as part of the initiative, which operates through the WHO Hub for Pandemic and Epidemic Intelligence and is aimed at supporting such goals as “scaling global capacity for genomic surveillance” and “improving outbreak detection.”

“Climate change is increasing both the risk of another global pandemic and the need to collaborate and share data,” Dr. Rajiv Shah, president of The Rockefeller Foundation, said at the time of the announcement.

Dr. Chikwe Ihekweazu, head of the WHO Hub for Pandemic and Epidemic Intelligence, said at the time of the announcement that “The COVID-19 pandemic underscored that disease surveillance, collaboration between stakeholders, and data sharing were absolutely essential ingredients for health security.”

Separately, a 2023 study published in The BMJ by Ginkgo Bioworks researchers warned that “Climate and land-use changes are predicted to increase the frequency of zoonotic spillover events, which have been the cause of most modern epidemics.”

“This trend can be altered by concerted global efforts to improve our capacity to prevent and contain outbreaks,” the paper stated, calling for the “rapid development” of mRNA vaccines, genomic surveillance and “focus surveillance at key travel hubs.”

And data.org, an initiative established by the Rockefeller Foundation and Mastercard with financial backers including Microsoft and the Wellcome Trust, launched the Capacity Accelerator Network (CAN), which aims to “build talent to solve systemic challenges such as those at the intersection of climate change and health.”

One way CAN says it can accomplish this is by “training 1 million, purpose-driven data practitioners by 2032 through a global ecosystem of academic, philanthropic, social impact, government, and private sector partners.”

Suggest A Correction

Share Options

Close menu

Republish Article

Please use the HTML above to republish this article. It is pre-formatted to follow our republication guidelines. Among other things, these require that the article not be edited; that the author’s byline is included; and that The Defender is clearly credited as the original source.

Please visit our full guidelines for more information. By republishing this article, you agree to these terms.